- Report
- December 2024
Global
From €6692EUR$7,500USD£5,901GBP
- Report
- September 2025
- 50 Pages
United States
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 45 Pages
Canada
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
Australia
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 38 Pages
India
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
Germany
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 47 Pages
France
From €4457EUR$4,995USD£3,930GBP
- Report
- August 2024
- 96 Pages
North America
From €5349EUR$5,995USD£4,717GBP
- Report
- August 2024
- 135 Pages
Europe
From €5349EUR$5,995USD£4,717GBP
- Report
- August 2024
- 126 Pages
Asia Pacific
From €5349EUR$5,995USD£4,717GBP
- Report
- September 2025
- 37 Pages
Brazil
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
Mexico
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 38 Pages
Japan
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 38 Pages
China
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
South Korea
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
Russia
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 38 Pages
Spain
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 37 Pages
Italy
From €4457EUR$4,995USD£3,930GBP
- Report
- September 2025
- 39 Pages
United Kingdom
From €4457EUR$4,995USD£3,930GBP
- Report
- August 2024
- 108 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5349EUR$5,995USD£4,717GBP

In the sphere of cardiovascular devices, short-term circulatory support devices are specialized medical apparatuses designed to aid the heart in pumping blood when the patient's cardiac function is insufficient, typically during or after surgeries, or during severe episodes of heart failure. These devices, including intra-aortic balloon pumps (IABPs), ventricular assist devices (VADs), and extracorporeal membrane oxygenation (ECMO) machines, are utilized to maintain hemodynamic stability and organ perfusion, facilitating the recovery of the heart's pumping ability or serving as a bridge to more definitive interventions such as heart transplantation or the implantation of long-term assist devices.
This market encompasses a variety of technologies, each tailored to address the differing needs and durations of circulatory support required by patients with compromised heart function. The products in this niche are characterized by ongoing technological advancements aimed at improving patient outcomes, ease of use, and minimizing complications.
Among the companies active in the short-term circulatory support devices market are Abiomed, which specializes in the Impella heart pump line, Medtronic, known for its intra-aortic balloon pumps, and Getinge, manufacturer of Cardiohelp, a portable ECMO device. Other notable market participants include LivaNova and Teleflex, each contributing to the development and supply of these essential cardiovascular support technologies. Show Less Read more